CancerNetwork Members: Login | Register
 
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

Psychiatric Times. Vol. 27 No. 8
NEWS 

45,000 More Psychiatrists, Anyone?

by Daniel Carlat, MD | August 3, 2010
Dr Carlat is associate clinical professor of psychiatry at Tufts University School of Medicine in Boston and editor in chief of The Carlat Psychiatry Report—a monthly newsletter on psychopharmacology. The Carlat Psychiatry Blog (www.carlatpsychiatry.blogspot.com) is consistently ranked as one of the 10 most influential health blogs. Dr Carlat is also a regular contributor to “The Couch In Crisis” blog on www.psychiatrictimes.com where this commentary is posted.

Houston, we have a problem. There is a critical shortage of psychiatrists. And the problem is not in Houston alone-- it includes the entire state of Texas, and every other state in the union (Mid-town Manhattan, Boston-- Beacon Hill, and Sacramento Street in San Francisco might be exceptions).

According to the most recent of studies commissioned by the government, America is shy about 45,000 psychiatrists. And the shortage will get worse, because many psychiatrists are reaching retirement age.

Before commenting on possible solutions, let's get a better fix on where this rather astounding number comes from. After all, labor statistics are politically charged quantities because they are often used as ammunition for various stakeholders to win funding for pet programs. So it's important to be skeptical.

The underlying data were published as a series of 3 articles in the October 2009 issue of Psychiatric Services. The research was commissioned by the Health Resources and Services Administration and was done by researchers at the Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill. Here I'll focus on the study by Konrad and colleagues,1 since it provides a good overview of the entire project. To facilitate ease of reading, I am not including all the references to other studies discussed in the original paper. I urge interested readers to peruse the original article for more details.

These researchers started with what they considered to be the most reliable recent estimates of the prevalence of mental illness in this country--the National Comorbidity Survey Replication (NCS-R) of 2001. That study was a random house-to-house survey of more than 9000 people. The authors did not want to simply use the NCS-R's figures at face value because that would have included many people whose mental illnesses are not particularly severe. Instead, they identified only those people who were functionally impaired and who had what they defined as "serious" mental illness--bipolar disorder, major depressive disorder, agoraphobia, generalized anxiety disorder, panic disorder, posttraumatic stress disorder, social phobia, or specific phobia.

You'll notice some glaring omissions here--most notably schizophrenia, substance abuse, and ADHD. Why weren't these included? There are various reasons, some having to do with the quality of the data they had to work with. The NCS-R data, oddly enough, did not include enough questions to reliably diagnose schizophrenia, so the researchers decided they could not come up with reliable prevalence numbers for schizophrenia. What about substance abuse? While the NCS-R data included substance abuse, there is little reliable data on how many substance abuse clinicians are out there, so they omitted this diagnosis from their analysis. And then there were a number of diagnoses the authors considered not serious enough to include--such as ADHD, conduct disorder, oppositional defiant disorder, dysthymia, and a few others.

The bottom line is that given the exclusion of many patients with disorders that required some kind of treatment, the study results are necessarily very conservative. Whatever shortage of services they discover will need to be amplified to make up for these uncounted patients. Nonetheless, using their particularly strict and conservative criteria, they estimated that the 1-year prevalence of "serious mental illness" in the US is 3.9%. The authors note that this estimate is very close to other recent estimates of the prevalence of significant disabling mental illness.

How much mental health treatment do these patients need? Using more data from NCS-R, the researchers stated that "about half of adults with serious mental illness used services; they typically spent 10.54 hours per year (95% confidence interval (CI), 5.46 to 15.63) with nonprescriber mental health professionals and 4.38 hours per year (CI, 3.40 to 5.37) with primary care physicians or prescriber mental health professionals."

Do these numbers sound right? Essentially, they are saying that patients with serious mental illness have about 1 therapy visit per month, and about 20 minutes per month of psychopharm-oriented visits with some prescriber. It sounds fairly realistic as an average, considering that some "stable" patients probably never see a therapist and just see their psychiatrist every 3 months or so for a medication refill, while on the other end of the spectrum, there are very ill patients who have at least weekly therapy sessions and biweekly psychopharmacological visits.

So how many mental health providers are needed? Now that the researchers estimated the number of patients with mental illness, the number of hours of care needed on average by each patient, and the amount of care provided by the average full-time clinician (I don't have the space to detail how they got that statistic, but it was derived from various surveys of practice patterns from the APA and other sources), they could calculate the bottom line--how many clinicians does the US need to treat its mentally ill citizens? They estimated that we need 25.9 psychiatrists per 100,000 population. This is an average number, which varies by county--typically, poorer people need more psychiatric time, so the need for help is greater in poorer counties.

The problem is that we only have roughly 10 per 100,000 practicing full-time psychiatrists in the US, or about 30,000 total. That's 15 per 100,000 too few, and assuming a population of about 300 million, we arrive at the estimated shortage of 45,000 psychiatrists. This is a very rough estimate to be sure--let's call it 45,000 plus or minus 15,000. Either way, it represents a mental health services crisis.

So--what are we going to do to solve this problem? I'm not sure, but here are some potential options:

1. Let's get the primary care physicians (PCPs) to absorb our excess patients. Sorry, but as family practitioner and writer Michael Victoroff once told me, "that donkey is overloaded already." PCPs are dealing with longer wait lists than psychiatrists and they are coping with a vast array of illnesses to manage. Outcomes research has shown that PCPs don't do the best job of treating psychiatric problems. For example, a recent study found that the mental health care dropout rate from PCPs was 32%--more than double the dropout rate from psychiatrists.2

These data are hardly surprising, since PCPs have barely enough time to hand out a pill and refer to a social worker, psychologist, or psychiatrist. And the psychiatrist will often be either unavailable or will refuse the patient's insurance.

2. Let's churn out more psychiatrists. That means expanding residency programs. That's a nice idea, but who is going to foot the bill? Medicare pays for the vast majority of residency slots in the US, and the going rate is upwards of $100,000 per slot. Is Medicare planning to shell out 45,000 3 $100,000 = $4.5 billion to solve the mental health access problem? Unlikely--in fact, we were lucky that President Obama's health care reform package is allocating $168 million to create only 600 more primary care physician residency slots. Most psychiatry residency directors feel lucky if they can simply hold on to the reimbursed positions they have now.

3. Let's train more advanced practice nurses and physician assistants. That might work over the long term, because the economics are more feasible. Physician extenders' training is shorter and less expensive, their incomes are lower, and they typically are more likely to work for underserved populations. One problem: they get very little training in psychology or psychotherapy--limiting their ability to properly diagnose and treat tough cases.

4. Let's give medically trained psychologists prescriptive authority. Though unpopular among psychiatrists, this is an increasingly viable solution. Psychologists with 2-year psychopharmacology masters degrees have been prescribing safely for 20 years in the military and for slightly less than a decade in New Mexico and Louisiana. (For a thorough review of this issue, see the recently published book Pharmacotherapy for Psychologists: Prescribing and Collaborative Roles.3 Our APA maintains an active and expensive lobbying program in order to defeat prescriptive authority legislation as it surfaces yearly in dozens of states. It may be time for us to reconsider whether this is money well spent. In my opinion, our battle against psychologists prescribing represents a short-sighted attempt to defend our professional turf at the expense of our primary responsibility, which is enhancing our patients' access to high-quality care.

Dr Carlat is associate clinical professor of psychiatry at Tufts University School of Medicine in Boston and editor in chief of The Carlat Psychiatry Report--a monthly newsletter on psychopharmacology. The Carlat Psychiatry Blog (www.carlatpsychiatry.blogspot.com) is consistently ranked as one of the 10 most influential health blogs. Dr Carlat is also a regular contributor to "The Couch In Crisis" blog on www.psychiatrictimes.com where this commentary is posted.

References

1. Konrad TR, Ellis AR, Thomas KC, et al. County-level estimates of need for mental health professionals in the United States. Psychiatr Serv. 2009;60:1307-1314.
2. Olfson M, Mojtabai R, Sampson NA, et al. Dropout from outpatient mental health care in the United States. Psychiatr Serv.2009;60:898-907.
3. McGrath RE, Moore BA, eds. Pharmacotherapy for Psychologists: Prescribing and Collaborative Roles.Washington, DC: American Psychological Association; 2010.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Robert Peers | December 11, 2010 11:14 PM EST

The problem is not a shortage of mental health professionals, whose beneficial effects are very limited, either by drug side-effects, or by limited long-term efficacy of both drugs and CBT. The real problem is a woeful lack of brain-oriented preventive and therapeutic DIETITIANS, plus a dearth of psychiatrists and psychologists interested in NUTRITIONAL NEUROSCIENCE. The common psychobrain disorders, anxiety and unipolar depression, both have nutritional origins: fatty maternal diet (especially since about 1800, in the fat-loving Western nations) produces neurosis by slightly inflaming the placenta, allowing maternal cortisol to reach and re-programme the foetal brain into an anxious organ, by epigenetically impairing glucocorticoid receptor gene expression. About 20-25% of Westerners, and lots of offspring of fat-loving immigrant ethnic groups, are affected--permanently. Anxious offspring often comfort-eat sweet or savoury fatty foods like chocolate or cheese, and end up with diabetes, obesity, vascular disease, arthritis, muscle wasting and Parkinson's disease. Also depression, which abates in two weeks with strict low-fat diet, while the underlying anxiety reverses quickly with Inositol supplement, 5 gm/day (it blocks CRF action, by inhibiting serotonin 2A receptors). Since hearing about Inositol's effects on depression and panic in 1999 (J Levine, Beersheeva, 1997), I have reversed anxiety in 3000 typical cases in family practice: in anyone with a history of childhood shyness or sensitivity, plus lifelong worrying, it never fails, except for a reduced response in cases not adhering to low-fat diet (which causes brain oxidation and inflammation [B Culver, Laramie]). That solves anxiety and common depression. As for the low-prevalence, but more severe, psychobrain disorders, schizophrenia and bipolar disorder have both sprung up in prevalence and severity--along with the neuroses--since about 1800 in the West, with Dr Edward Hare claiming, from his detailed research, that schizophrenia, for example, was rare or unknown in England and Europe before that date, when there was no need to build lunatic asylums (Maudsley Lecture, Brit J Psych 1982). There is no evidence that the genes, acting in isolation, cause anything worse than Mild Schizotypy and Benign Unipolar Hypomania (or Benign Outgoing Personality [BOP] as in Teddy Roosevelt, a successful BOPPER, while Winston Churchill was mixed "BOP"OLAR/BIPOLAR, depending on his current cheese intake). What converts a benign genetic outcome to full-blown malignant psychosis is 1) fatty maternal diet, causing anxiety (up to 2/3 of schizophrenia cases, about half of bipolar 2 cases, and a resounding 93% of bipolar cases), and 2) fatty personal diet (often driven by anxiety-related comfort-eating), which causes faulty, polyunsaturate-depleted cell membranes, with ensuing insulin resistance and widespread oxidation and inflammation, the latter also affecting the brain, both directly (B Culver) and via inflammatory systemic cytokines (B Baune). The challenge in psychiatry, then, is 1) to get our patients on to low-fat diet, 2) to reverse anxiety effectively, which can be done within 7 days with Inositol supplement, 5 gm/day. This simple regimen cures anxiety and unipolar depression within a fortnight (interestingly, Dr M Aboukhatwa, in Philadelphia, has found that antidepressants work mainly by putting more endogenously-synthesized Inositol in expanded neuronal membranes, thus promoting BDNF formation and hippocampal neurogenesis: why not just take Inositol direct, and skip the outmoded drugs, with their side-effects, like impaired libido?--Inositol IMPROVES libido in my anxious patients!). The same dietetic regimen may lead us to The Promised Land in both psychoses as well--I see much better mood, cognition and physical health in my schizophrenia and bipolar cases following diet plus Inositol. In theory, neither anti-psychotic drugs, nor mood-stabilizers, should be needed in the long-term, to successfully reduce these disorders to their pure phenotypes. I have a number of creative BIPOLAR patients now converted back to "BOP"OLAR and healthy lifestyle, whose creativity is now flowering. This corrective Nutritional Neuroscience regimen requires no help from outmoded empirical brain drugs: it is scientific, not empirical, and can be used by ANY mental health professional, from social worker through to fully-fledged psychiatrist. Finally, as a sweetener, Inositol is ALSO anti-ageing! It activates 100s of anti-ageing genes (J Barger, 2008), promising 1) unusual mental and physical energy, and 2) a very long healthy life, to your mental health patients, who will hug you in gratitude, and send you Xmas presents!

by John Moloney | October 30, 2010 1:43 PM EDT

hi,  i wonder where the present Psychiatrists are finding patients with insurance, theat can afford to pay een a small part of their bill, that can find a Psychiatrist that accepts Medicaid or Medicare, or that doesn't think anything more than a yearly gvisit is beyond their ability to pay. I think the so-called paying patient is becoming rare, and those that can are grabbed hold of by any treating Psychiatrist or therapist . This has appearred to escalate as the economic status, from jobs, to foreclosures, to college expenses, to forced insurance , etc., has just kept right on going down the tubes. John Moloney, MD Peoria, IL

by Dean Cutillar | October 21, 2010 4:47 PM EDT

Psychologists prescribing?  Well, from my experience, Psychologists are not very good at diagnosis, and an accurate dx is the first step to a good treatment plan.  They are good at therapy though.

 

D.

by Marla McCall | October 17, 2010 12:00 AM EDT

I agree with JDee Richarson. Psychologists do not have the training in biochemistry, physiology, disease processes, and so forth to adequately monitor patients who are being prescribed potentially dangerous medications, and who may also have multiple other medical problems. As I psychiatric nurse practitioner, my expertise is in the medical aspects of prescribing (metabolic monitoring as needed), coordination of care with other medical practitioners, as well as patient teaching. I have at least as much trainng in psychotherapeutic and group techniques as most licensed therapists. I do not pretend to be an expert in psychological testing, or in depth therapy and I do refer my medication patients to competent therapist for all but brief therapies while I primarily handle dignostics and medication management. I believe this is efficient use of a mid level practitioner. Most of my patients think that I am the most thorough and caring "psychiatrist" they have seen--though I always correct them as to my licensure and role. MSN, Psychiatric Mental Health Nurse Practitioner.

by george george gharda-ward | October 08, 2010 7:05 PM EDT

Imagine a ladder. At the top of the ladder is the most "powerful"person on that ladder. In this case it is Psychiatrists, in the "treatment" of mental illness. Grabbing on their legs to pull themselves up are psychiatric PA's, PhD psychologists, Psychiatric A.R.N.P.'s. A step below, RN's. MSW's, then LPN's etc. Since everyone is pushing themselves up the ladder, it is becoming top heavy. We will soon topple over under the weight of our egos and paychecks. And all the King's Horses and all the King's Men can't put the chaos of "mental health" together again. Those who will suffer the most? Our Patients!

Article Comment Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 Next






References

1. Konrad TR, Ellis AR, Thomas KC, et al. County-level estimates of need for mental health professionals in the United States. Psychiatr Serv. 2009;60:1307-1314.
2. Olfson M, Mojtabai R, Sampson NA, et al. Dropout from outpatient mental health care in the United States. Psychiatr Serv.2009;60:898-907.
3. McGrath RE, Moore BA, eds. Pharmacotherapy for Psychologists: Prescribing and Collaborative Roles.Washington, DC: American Psychological Association; 2010.


 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 

 
PUBLICATIONS
ONCOLOGY Journal ONCOLOGY Nurse Edition Journal Cancer Management: A Multidisciplinary Approach

ONCOLOGY:
Perspectives on Best Practices

ONCOLOGY:
Nurse Edition

CANCER
MANAGEMENT
:
A Multidisciplinary
Approach


 
IMAGE IQ

Other than surgical interventions, which medication might be most appropriate for this patient?

A 68-year-old woman presented with a mass on the scalp. An incisional biopsy of the scalp mass and an excisional biopsy of the lymph node both revealed basal cell carcinoma.

 

More Image IQs:

 

 
FROM PHYSICIANS PRACTICE
'What They Should Really Teach in Medical School'
Julie Schopps, MD , February 6, 2012
The North Carolina-based pediatrician weighs in on why she thinks the real learning doesn't take place until students are out of the classroom.
Improve EHR Systems by Rethinking Medical Billing
Daniel Essin, MA, MD, February 6, 2012
Separating billing-related data from other clinical documentation and transmitting it to a billing system is not difficult …no matter how the charting is done.
Keeping Your Medical Practice’s Accounts Receivable on Track
P.J. Cloud-Moulds, February 4, 2012
Here are the minimum reports you should be running to keep an eye on your practices A/R.
Healthcare Providers Play Crucial Role in Helping Victims of Abuse
Stephen Hanson, PA-C , February 3, 2012
I would urge each and every one of you to be familiar with the warning signs of abuse, and the resources available to you all as healthcare providers.
Protecting Your Medical Practice's Data
Marisa Torrieri, February 3, 2012
Here's the scoop on how to implement a good data-backup plan at your office.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Management of Brain Metastases: Neurosurgical Considerations
  • Head and Neck Tumors
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • Younger Breast Cancer Patients Have More Adverse Quality of Life Issues
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • AL Amyloidosis: Who, What, When, Why, and Where
  • The Maze of PARP Inhibitors in Ovarian Cancer
  • The Circuitous Path of PARP Inhibitor Development in Epithelial Ovarian Cancer
  • Podcast: Dr. David Ahlquist on Advances in Colorectal Cancer Screening
  • Lung Cancer Screening: A New Era
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs



CancerNetwork on Facebook

 

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy